Variation in the detection, signaling, and repair of DNA damage contributes to human cancer risk. To assess capacity to modulate endogenous DNA damage among radiologic technologists who had been diagnosed with breast cancer and another malignancy (breast-other; n=42), early-onset breast cancer (early-onset, age ≤ 35; n=38), thyroid cancer (n=68), long-lived cancer-free individuals (hyper-normals; n=20) and cancer-free controls (n=49) we quantified DNA damage (single strand breaks and abasic sites) in untreated lymphoblastoid cell lines using the alkaline comet assay. Komet™ software provided comet tail length, % DNA in tail (tail DNA), comet distributed moment (CDM), and Olive tail moment (OTM) summarized as the geometric mean of 100 cells. Category cut-points (median and 75 th percentile) were determined from the distribution among controls. Tail length (for ≥ 75% vs. below the median, age adjusted) was most consistently associated with the highest odds ratios in the breast-other, early-onset, and thyroid cancer groups (with risk increased 10-, 5-or 19-fold, respectively, with wide confidence intervals) and decreased risk among the hyper-normal group. For the other three Comet measures, risk of breast-other was elevated approximately three-fold. Risk of early-onset breast cancer was mixed and risk of thyroid cancer ranged from null to a two-fold increase. The hyper-normal group showed decreased odds ratios for tail DNA and OTM, but not CDM. DNA damage, as estimated by all Comet measures, was relatively unaffected by survival time, reproductive factors, and prior radiation treatment. We detected a continuum of endogenous DNA damage that was highest among cancer cases, less in controls, and suggestively lowest in hyper-normal individuals. Measuring this DNA damage phenotype may contribute to the identification of susceptible sub-groups. Our observations require replication in a prospective study with a large number of pre-diagnostic samples. 3
IntroductionThere is considerable evidence that individual variation in the detection, signaling, toleration, and repair of DNA damage (from internal and external exposures and intrinsic instability of DNA) contributes to human cancer risk (reviewed in [1][2][3][4][5][6]). Several studies (with sample sizes in excess of 20 cases and 20 controls) have reported increased breast [7,8] and bladder [9] cancer risks associated with higher DNA damage measured by the comet assay [10]. In these studies elevated endogenous damage and post-mutagen challenge damage levels were associated with increased cancer risk. These results indicate that elevated endogenous damage is itself a risk factor, and are consistent with the notion that measures of endogenous damage are correlated with damage repair capability after an exogenous challenge.We characterized risk of solid cancer associated with ability to limit DNA damage from endogenous DNA metabolic processes among persons with selected malignancies, compared to controls by quantifying single strand DNA breaks (SSB) and abasic sites...